系统性红斑狼患者中COVID-19的严重程度
Kishor R Danao1, Vijayshri V Rokde1, Ujwala N Mahajan1
1Department of Pharmaceutical Chemistry, Dadasaheb Balpande College of Pharmacy, Nagpur, 440037, Maharashtra, India.
Infectious disorders drug targets
|December 23, 2024
概括
系统性红斑狼 (SLE) 患者具有独特的免疫系统缺陷,增加感染易感性. 免疫抑制治疗可能有助于减轻这些人的COVID-19风险.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 类风湿病学 类风湿病学
背景情况:
- 系统性红斑狼 (SLE) 是一种自身免疫性疾病,其特点是自身抗体和对自身抗原的耐受性降低.
- 患有SLE的患者经常表现出缺血补充和降低免疫球蛋白 (Ig) 水平,增加感染风险.
- 在SLE中异常免疫反应包括淋巴缺血症,T细胞功能异常,以及高水平的促炎细胞因子.
研究的目的:
- 在COVID-19大流行期间,探索系统性红斑狼 (SLE) 患者免疫系统的反应.
- 了解COVID-19感染如何影响SLE患者的免疫系统.
- 评估免疫抑制疗法在SLE患者的COVID-19管理中的作用.
主要方法:
- 审查关于SLE,COVID-19和免疫反应的现有文献.
- 分析免疫细胞功能,自身抗体的产生,以及在SLE中细胞因子的分析.
- 检查免疫抑制药物对SLE患者COVID-19的影响.
主要成果:
- COVID-19 感染可以显著增强I型干扰素反应.
- 结核病患者表现出CD8 T细胞反应受损,影响着细胞和化学反应.
- 低补充血和降低的免疫球蛋白水平在SLE中很常见,与感染易感性相关.
结论:
- SLE患者具有固有的免疫脆弱性,使他们易受感染,包括COVID-19.
- 免疫抑制治疗,如皮质类固醇,雅努斯激酶抑制剂 (JAK) 和托西利祖马布,可以改善免疫功能,降低SLE患者的COVID-19易感性.
- 需要进一步的研究来充分阐明SLE,COVID-19和治疗干预措施之间的复杂相互作用.
相关概念视频
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Autoimmune Disorders
385
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
385
COPD: Pathogenesis and Clinical Features
231
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
231
Immunodeficiency Diseases
899
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
899
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


